Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 15.5% in the year so far compared with the industry’s decline of ...

BofA has reinstated coverage of 11 large-cap pharmaceutical and biotech stocks, with Eli Lilly (LLY), Gilead (GILD) and Merck ...

Biotech companies are making monumental strides in cancer treatment, leveraging cutting-edge technologies to redefine the ...

Investing.com -- Bank of America reinstated coverage of 11 major U.S. pharmaceutical and biotech stocks in a note Tuesday, ...

BofA reinstated coverage of Regeneron (REGN) with an Underperform rating and $565 price target The firm calls Regeneron a “high-quality ...

Shares of Kodiak Sciences (KOD) rallied 32% Monday after Jefferies upgraded the stock to buy from hold, citing the company’s turnaround and upcoming catalysts. Read more here.

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Representative Josh Gottheimer also recently made the following trade(s): Shares of REGN stock opened at $778.00 on Friday. The business has a 50-day moving average price of $882.14 and a two-hundred ...